Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, $0.001 Par Value
-
Shares outstanding
-
117M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
33.5M
-
Shares change
-
+28.3M
-
Total reported value, excl. options
-
$376M
-
Value change
-
+$318M
-
Number of buys
-
59
-
Price
-
$11.23
Significant Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value (COGT) as of Q4 2020
66 filings reported holding COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value as of Q4 2020.
Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value (COGT) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.5M shares
of 117M outstanding shares and own 28.76% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.19M shares), Logos Global Management LP (1.92M shares), JANUS HENDERSON GROUP PLC (1.73M shares), Ally Bridge Group (NY) LLC (1.62M shares), Fairmount Funds Management LLC (1.56M shares), BVF INC/IL (1.53M shares), Polar Capital Holdings Plc (1.19M shares), Ghost Tree Capital, LLC (1.1M shares), VR Adviser, LLC (1.09M shares), and RA CAPITAL MANAGEMENT, L.P. (1.03M shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.